Abstract
Objective: To review the efficacy and safety of crizanlizumab (Adakveo) in the prevention of vaso-occlusive pain crises in sickle cell disease. Data S......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
